Abstract:Background: Candida albicans is an opportunistic pathogen commonly found in human mucous membranes. In light of the escalating challenge posed by antibiotic resistance of C. albicans strains worldwide, it is an urgently necessary to explore alternative therapeutic options. Objective: This study aims to assess the efficacy of two Cinnamaldehyde derivatives, 2-Cl Cinnamaldehyde (2-Cl CA) and 4-Cl Cinnamaldehyde (4-Cl CA), against C. albicans through both in vitro experiments and in vivo murine models and to evaluate their potential as new drug candidates for treating C. albicans. Methods and results: The minimum inhibitory concentrations (MICs) of Cinnamaldehyde 2-Cl and 4-Cl benzene ring derivatives against C. albicans were 25 μg/mL. Time-killing experiments revealed that both Cinnamaldehyde derivatives exhibited fungicidal activity against C. albicans at concentrations of 5 MIC and 10 MIC. In the checkerboard experiment, 4-Cl CA did not show any antagonistic effect when combined with first-line antifungal drugs. Instead, it exhibited additive effects in combination with nystatin. Both 2-Cl and 4-Cl CA demonstrated inhibitory activity against C. albicans biofilm formation, especially at 8 MIC and 16 MIC concentrations. In C. albicans biofilm eradication experiments, although high drug concentrations of 2-Cl and 4-Cl CA were unable to eradicate the biofilm completely, they were still effective in killing C. albicans cells within the biofilm. Moreover, sub-inhibitory concentrations of 4-Cl CA (ranging from 5 to 20 μg/mL) significantly inhibited cell aggregation and hyphal formation. Furthermore, 4-Cl CA effectively inhibited intracellular C. albicans infection in macrophages. Lastly, the effectiveness of 4-Cl CA was evaluated in a mouse model of hematogenous disseminated candidiasis caused by C. albicans, which revealed that 4-Cl CA significantly reduced fungal burden and improved mouse survival compared to the untreated controls. Conclusion: The 4-Cl CA exhibited inhibitory effects against C. albicans through both in vivo and in vitro models, demonstrating its therapeutic potential as a promising new drug candidate for treating drug-resistant candidiasis albicans.

Antifungal evaluation of quinoline-chalcone derivatives combined with FLC against drug-resistant Candida albicans.

Novel Potentially Antifungal Hybrids of 5-Flucytosine and Fluconazole: Design, Synthesis and Bioactive Evaluation.

Synthesis and antifungal evaluation of phenol-derived bis(indolyl)methanes combined with FLC against Candida albicans

Antifungal Activity of the Ethanol Extract from Flos Rosae Chinensis with Activity Against Fluconazole-Resistant Clinical Candida

Antifungal Activity and Potential Mechanism of 6,7, 4′-O-Triacetylscutellarein Combined With Fluconazole Against Drug-Resistant C. albicans

Discovery of Deguelin Derivatives in Combination with Fluconazole Against Drug-Resistant Candida Albicans

Anti- Candida Activity of New Azole Derivatives Alone and in Combination with Fluconazole

Cyclometalated iridium(III) complexes combined with fluconazole: antifungal activity against resistant C. albicans

Antifungal Activity of Rubus Chingii Extract Combined with Fluconazole Against Fluconazole-Resistant Candida Albicans

Combination of fluconazole with natural compounds: A promising strategy to manage resistant Candida albicans infections

Synergistic Effect of the Combination of Deferoxamine and Fluconazole in Vitro and in Vivo Against Fluconazole-Resistant Candida Spp.

Synergistic Antifungal Effects of Curcumin Derivatives As Fungal Biofilm Inhibitors with Fluconazole.

Design,synthesis and evaluation of the compounds combined with fluconazole against drug resistant Candida albicans

Synergistic Antifungal Effect of Fluconazole Combined with Licofelone Against Resistant Candida Albicans

Antifungal Effects of Phytocompounds on Candida Species Alone and in Combination with Fluconazole.

Synthesis and antifungal evaluation of novel triazole derivatives bearing a pyrazole-methoxyl moiety

New azole derivatives linked to indole/indoline moieties com-bined with FLC against drug-resistant C. albicans

The Synthesis and Synergistic Antifungal Effects of Chalcones Against Drug Resistant Candida Albicans.

The Effect of Ginkgolide B Combined with Fluconazole Against Drug-Resistant Candida Albicans Based on Common Resistance Mechanisms

Synthesis and Synergistic Antifungal Effects of Monoketone Derivatives of Curcumin Against Fluconazole-Resistant Candida Spp.

Antifungal activity of Cinnamaldehyde derivatives against fluconazole-resistant Candida albicans